In 1863, two entrepreneurs - Friedrich Bayer and Johann Friedrich Weskott - established a small dye business in Barmen, Germany, with a vision to transform the textile industry through chemistry. What began as "Friedr. Bayer et comp." quickly evolved into something far greater. As they mastered the science of synthetic dyes, they discovered something profound: the same chemical principles could revolutionize medicine. By the late 19th century, Bayer had introduced Aspirin, a breakthrough that would shape modern healthcare and establish the company's commitment to improving lives through science.
Today, Bayer stands as a global life sciences leader, driven by the mission "Health for all, Hunger for none." The company's innovative pharmaceutical portfolio addresses critical diseases and unmet medical needs, while its Crop Science division advances sustainable agriculture through cutting-edge seeds, traits, and crop protection solutions. Under CEO Bill Anderson's leadership, Bayer continues to push boundaries, investing over $27 billion in R&D to tackle humanity's biggest challenges - from food security to climate resilience - proving that a 160-year-old company can still be a pioneer of tomorrow's breakthroughs.